1. Is Hypertension Treated Adequately?

   • L. Hansson
   • J. I. S. Robertson

   Introductory Lecture 18 October 2012 Pages: 1 - 6

2. Pharmacodynamic Properties of Felodipine

   • Bengt Ljung
   • M. Nordlander

   Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 7 - 15

3. Clinical Pharmacokinetics of Felodipine

   • Boo Edgar
   • P. Lundborg
   • C. G. Regårdh

   Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 16 - 27

4. Pharmacokinetics and Haemodynamics of Felodipine as Monotherapy in Hypertensive Patients

   • Boo Edgar
   • P. Collste
   • C. G. Regårdh

   Short Communication 18 October 2012 Pages: 28 - 29

5. Pharmacokinetics and Haemodynamics of Felodipine in Hypertensive Patients Treated Concomitantly with a β-Blocker

   • Dag Elmfeldt
   • B. Bengtsson
   • O. Rönn

   Short Communication 18 October 2012 Pages: 30 - 30

6. Effects of Impaired Renal Function on the Pharmacokinetics of Felodipine

   • Boo Edgar
   • M. Aurell
   • C. Shansky

   Short Communication 18 October 2012 Pages: 31 - 32

7. Pharmacokinetics of Felodipine and Effect on Digoxin Plasma Levels in Patients with Heart Failure

   • Nina Rehnqvist
   • E. Billing
   • G. Olsson

   Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 33 - 42

8. Metabolism of [¹⁴C] Felodipine, a New Vasodilating Drug, in Healthy Volunteers

   • K. -J. Hoffmann
   • L. Andersson

   Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 43 - 52

9. Baroreflex Control of Renin Release in Spontaneously Hypertensive Rats after Administration of Felodipine

   • Margareta Nordlander
   • R. Horton
   • P. Thalén

   Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 53 - 56

10. Poster Discussion: Section 1

    • G. DiBona

    Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 57 - 58

11. Renal Effects of Felodipine in Hypertension

    • G. Leonetti
    • L. Terzoli
    • Alberto Zanchetti

    Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 59 - 66

12. Effect of Long Term Felodipine Treatment on Renal Vascular Tone, Glomerular Filtration Rate and Renal Tubular Function in Essential Hypertension

    • U. Lennart Hulthén
    • P. L. Katzman
    • B. Hökfelt

    Short Communication 18 October 2012 Pages: 67 - 68

13. Haemodynamic Effects of Felodipine during Supine Resting and Exercising States and Orthostatic Tilt in Patients with Chronic Congestive Heart Failure

    • E. Kassis
    • S. Waldorff
    • O. Amtorp

    Short Communication 18 October 2012 Pages: 69 - 70

14. Felodipine in Ischaemic Heart Disease

    • J. V. Sheridan
    • P. Thomas
    • D. J. Sheridan

    Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 71 - 78

15. Felodipine in Heart Failure

    • Peter H. J. M. Dunselman
    • C. E. E. Kuntze
    • K. I. Lie

    Short Communication 18 October 2012 Pages: 79 - 80

16. Haemodynamic Effects of Felodipine in Congestive Heart Failure

    • P. Held
    • K. Swedberg

    Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 81 - 84

17. The Effects of Felodipine on Left Ventricular Function in β-Blocked Patients

    • A. J. Drake-Holland
    • S. Pugh
    • M. I. M. Noble

    Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 85 - 86

18. Hormonal and Blood Pressure Responses to Tilting in β-Blocked Essential Hypertension Treated with Felodipine or Prazosin

    • B. Jackson
    • B. P. McGrath
    • C. I. Johnston

    Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 87 - 92

19. Glucose Tolerance and Secretion and Clearance of Insulin during Long Term Felodipine Treatment

    • P. L. Katzman
    • U. Lennart Hulthén
    • B. Hökfelt

    Short Communication 18 October 2012 Pages: 93 - 94

20. Poster Discussion: Section 2

    • G. DiBona

    Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 95 - 96

21. Felodipine in Hypertensive Patients

    • H. E. Sluiter

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 97 - 106

22. Felodipine Monotherapy in Hypertension

    • W. A. Littler
    • S. A. Smith
    • P. J. E. Mace

    Short Communication 18 October 2012 Pages: 107 - 108

23. Felodipine versus Prazosin as an Addition to a β-Blocker in the Treatment of Essential Hypertension

    • B. Jackson
    • T. O. Morgan
    • A. Anderson

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 109 - 119

24. The Use of Felodipine in the Treatment of Severe Hypertension

    • A. L. Muir
    • C. G. Wathen

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 120 - 124

25. Comparison of Antihypertensive Effect and Pharmacokinetics of Conventional and Extended Release Felodipine Tablets in Patients with Arterial Hypertension

    • T. Hedner
    • D. Elmfeldt
    • E. Sjögren

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 125 - 131

26. Aspects on the Benefit-Risk Balance of Felodipine in Hypertension

    • Dag Elmfeldt
    • S. Westerling

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 132 - 135

27. Felodipine versus Hydrochlorothiazide as an Addition to a β-Blocker in the Treatment of Hypertension

    • Harry Borgmästars
    • B. Forsén
    • H. Ibsen

    Short Communication 18 October 2012 Pages: 136 - 138

28. Felodipine, a New Calcium Antagonist, as Monotherapy in Mild or Moderate Hypertension

    • Cooperative Study Group
    • D. V. Hamilton

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 139 - 148

29. Hypertension in the Elderly

    • R. Harvard Davis
    • R. H. Burton
    • D. E. Ward

    Short Communication 18 October 2012 Pages: 149 - 150

30. Clinical Evaluation of Felodipine in Patients with Refractory Hypertension

    • H. Herlitz
    • S. Björck
    • M. Aurell

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 151 - 155

31. Felodipine in Combination with a β-Blocker and a Diuretic in Chronic Treatment of Patients with Refractory Primary Hypertension

    • Ove K. Andersson
    • T. Hedner
    • G. Granérus

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 156 - 160

32. Clinical Evaluation of Felodipine in Hypertensive Patients Previously Treated with a Triple Drug Regimen

    • Thomas Hedner

    Short Communication 18 October 2012 Pages: 161 - 161

33. Felodipine versus Moduretic®

    • B. Krönig
    • G. Flygt

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 162 - 169

34. Effects of Felodipine and Metoprolol on Blood Pressure, Plasma Renin, Angiotensin II, Aldosterone and Catecholamines in Hypertensive Patients

    • P. Lijnen
    • R. Fagard
    • A. Amery

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 170 - 175

35. A Dose-Response Study of Felodipine in Patients Remaining Hypertensive on a β-Blocker

    • Canadian Felodipine Study Group
    • A. G. Logan

    Short Communication 18 October 2012 Pages: 176 - 177

36. Short and Long Term Treatment of Essential Hypertension with Felodipine as Monotherapy

    • K. Harrington
    • P. Fitzgerald
    • K. O’Malley

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 178 - 185

37. Antihypertensive and Biochemical Effects of the Dihydropyridine Felodipine in the Long Term Treatment of Moderate to Severe Hypertension

    • H. E. Sluiter
    • F. Th. M. Huysmans
    • R. A. P. Koene

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 186 - 193

38. Felodipine Monotherapy in Systolic Hypertension in the Elderly

    • L. M. H. Wing
    • J. P. Chalmers
    • A. E. Russell

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 194 - 197

39. Poster Discussion: Section 3

    • A. R. Lorimer

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 198 - 202

40. Panel Discussion

    • A. Zanchetti
    • G. DiBona
    • J. I. S. Robertson

    Section 3: Felodipine in Hypertension 18 October 2012 Pages: 203 - 209